×
For best experience we recommend to activate Javascript in your browser.
CBL antibody (Tyr674)
This anti-CBL antibody is a Rabbit Polyclonal antibody detecting CBL in WB, ELISA and IHC. Suitable for Human.
Quick Overview for CBL antibody (Tyr674) (ABIN5617534)
Target
See all CBL Antibodies
CBL
(Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
Reactivity
All reactivities for CBL antibodies
Human
Host
All hosts for CBL antibodies
Rabbit
Clonality
All clonalities for CBL antibodies
Polyclonal
Conjugate
All conjugates for CBL antibodies
This CBL antibody is un-conjugated
Application
All applications for CBL antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-CBL Antibody
(hide)
Binding Specificity
All epitopes for CBL antibodies
Tyr674
Specificity
CBL antibody detects endogenous levels of total CBL protein
Cross-Reactivity (Details)
Mouse, Rat
Characteristics
Rabbit polyclonal CBL antibody
Purification
CBL antibody was purified by affinity chromatography
Immunogen
CBL antibody was raised in Rabbit using a synthesized non-phosphopeptide derived from human CBL around the phosphorylation site of tyrosine 674 (A-I-YP-S-L) as the immunogen
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:500 - 1:1000, IHC: 1:50 - 1:100, ELISA: 1:5000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied in liquid format, PBS buffer, pH 7.4, 150 mM NaCl with added preservative 0.02 % sodium azide and 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot and store at -20 deg C. Avoid repeated freeze thaw cycles
Target Details for CBL
(hide)
Target
CBL
(Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
Alternative Name
CBL
Pathways
TCR Signaling , Interferon-gamma Pathway , EGFR Signaling Pathway , EGFR Downregulation , VEGFR1 Specific Signals
Recently viewed
(hide)
Chat with us , powered by LiveChat